Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492

By sjmartinez • February 21, 2025

Girard N, Besada M, Rogula B, Lucherini S, Vo L, Chaudhary MA, Goring S, Lozano-Ortega G, Tran M, Varol N, Waser N, Yu WW, Lee JM, Spicer J. Correction: Girard et al. Comparative Efficacy of Neoadjuvant Nivolumab Plus Chemotherapy versus Conventional Comparator Treatments in Resectable Non-Small-Cell Lung Cancer: A Systematic Literature Review and Network Meta-Analysis. Cancers 2024, 16, 2492. Cancers (Basel). 2025 Feb 17;17(4):674. doi: 10.3390/cancers17040674. Erratum for: Cancers (Basel). 2024 Jul 08;16(13):2492. doi: 10.3390/cancers16132492. PMID: 39976394.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Age and Procedural Timing for Asymptomatic Severe Aortic Stenosis: Analysis From the EARLY TAVR Trial

Goel K, Lindman BR, Schwartz A, Cohen DJ, Giustino G, Oldemeyer JB, Strote J, Babaliaros V, Devireddy CM, Fischbein MP, Fearon WF, Daniels D, Spies[...]

Ziftomenib with venetoclax and azacitidine in relapsed/refractory NPM1-mutated acute myeloid leukemia

Wang ES, Erba HP, Zeidan AM, Roboz GJ, Altman JK, Advani AS, Lin TL, Strickland SA, Juckett MB, Pratz KW, Mangan JK, McMahon CM, Alsfeld[...]

Considerations and best practices for respirometry

Ball AB, Stiles L, Divakaruni AS. Considerations and best practices for respirometry. Cell Metab. 2026 Jun 2;38(6):1093-1096. doi: 10.1016/j.cmet.2026.05.001. PMID: 42229405.